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ADVANCING PSORIASIS TREATMENT 
Clinical drug evaluation of fumaric acid esters and TLR-antagonists  
I. Fumaric acid esters should be the primary choice for first-line systemic treatment 
in plaque psoriasis given their potential for a favourable long-term disease control. 
(this thesis)
II. Fumaric acid esters do not have a specific, targeted mode of action underlying 
their beneficial effects in psoriasis, but rather act through broad, disease-modifying 
immune-effects. (this thesis)
III. Conventional systematic psoriasis treatments such as fumaric acid esters and 
methotrexate still hold relevance in the era of biologic targeted treatments. (this 
thesis)
IV. Female patients treated long-term with fumaric acid esters seem in particular at risk 
to develop renal proximal tubuli damage. (this thesis)
V. Psoriasis is a useful model for proof-of-concept evaluations of novel immune-based 
compounds in immune-mediated inflammatory diseases, such as TLR-7, 8, and 9 
antagonists. (this thesis)  
VI. The psoriasis area and severity index (PASI) does not account for the patient’s view 
on disease severity and is therefore not suitable as primary outcome measure in 
clinical trials. (Hesselvig et al., Acta Derm Venereol, 2017)
VII. Adequate patient-education is one of the most important factors in establishing 
optimal treatment adherence. (Zschocke et al., J Eur Acad Dermatol Venereol, 2017)
VIII. Bio-similars in dermatology can be a substitution for the original biologic on the 
basis of a non-inferior efficacy and are essential to maintain cost-control in current 
health care systems. (Griffiths et al., Br J Dermatol. 2016)
IX. Stem-cell-mediated gene therapy of severe genodermatoses such as junctional 
epidermolysis bullosa is now within clinical reach. (Hirsch et al., Nature, 2017)
X. The everlasting tuberculosis epidemic in low- and middle-income countries 
demonstrates that tuberculosis is not just a disease problem, it is a health-system 
issue. (Bloom, N Engl J Med, 2018)
XI. De roltrap is de snelste weg naar het ziekenhuis.
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